A federal appeals court panel has begun hearing arguments in a case involving a Seattle doctor who sued the U.S. Drug Enforcement Administration for...
It's a road of dominance ahead for EVs, shows new report. Meanwhile local graphite stocks are up and lithium's in ... Read More The post High...
Merck has ended work on two separate Phase II studies of its small molecule for treatment-resistant depression and mild-to-moderate Alzheimer’s disease,...
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions....
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) CEO Joshua Bartch speaks to Thomas Warner from Proactive London about the biotechnology company’s...
Johnson & Johnson has released its 3rd quarter results and once again Spravato sales have shown impressive growth. The post Spravato Sales Lead J&J...
This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of the...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Pharma stocks and the biotech sector can offer explosive gains. It also offers incredibly crushing defeats in which share prices decline precipitously....
5-MEO-DMT developer GH Research has provided an update on its main clinical programs. The company is notoriously short on communications outside of the...